Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Orchard Therapeutics Announces Proposed ADS Ratio Change from One ADS to Ten Ordinary Shares

The Company anticipates that the ADS Ratio Change will be effective on or about March 10, 2023. For the company's ADS holders, the change in the ADS Ratio will have the same effect as a one-for-ten reverse ADS

The Company anticipates that the ADS Ratio Change will be effective on or about March 10, 2023. For the company’s ADS holders, the change in the ADS Ratio will have the same effect as a one-for-ten reverse ADS split and is intended to enable the company to regain compliance with the Nasdaq minimum bid price requirement.

Total
0
Shares
Related Posts
Read More

Exclusive: Radio Caca’s Vitaliy Tyan on the “truest” DAOs, NFTs, Metaverse, and Web 3.0 Reshaping Reality

My interview with Radio Caca's Head of Marketing Vitaliy Tyan was a great opportunity to get insights into how a DAO-governed company works, as well as to learn more about upcoming partnerships at RACA. Vitaliy also discussed his views on the interoperability of NFTs and the escapism of the Metaverse.

$BNB